Literature DB >> 22968953

Identification of suitable culture condition for expansion and osteogenic differentiation of human bone marrow stem cells.

Shiplu Roy Chowdhury1, Min Hwei Ng, Norazril Shamsul Abu Hassan, Bin Saim Aminuddin, Bt Hj Idrus Ruszymah.   

Abstract

This study was undertaken in order to identify the best culture strategy to expand and osteogenic differentiation of human bone marrow stem cells (hBMSCs) for subsequent bone tissue engineering. In this regard, the experiment was designed to evaluate whether it is feasible to bypass the expansion phase during hBMSCs differentiation towards osteogenic lineages by early induction, if not identification of suitable culture media for enhancement of hBMSCs expansion and osteogenic differentiation. It was found that introduction of osteogenic factors in alpha-minimum essential medium (αMEM) during expansion phase resulted in significant reduction of hBMSCs growth rate and osteogenic gene expressions. In an approach to identify suitable culture media, the growth and differentiation potential of hBMSCs were evaluated in αMEM, F12:DMEM (1:1; FD), and FD with growth factors. It was found that αMEM favors the expansion and osteogenic differentiation of hBMSCs compared to that in FD. However, supplementation of growth factors in FD, only during expansion phase, enhances the hBMSCs growth rate and significantly up-regulates the expression of CBFA-1 (the early markers of osteogenic differentiation) during expansion, and, other osteogenic genes at the end of induction compared to the cells in αMEM and FD. These results suggested that the expansion and differentiation phase of the hBMSCs should be separately and carefully timed. For bone tissue engineering, supplementation of growth factors in FD only during the expansion phase was sufficient to promote hBMSCs expansion and differentiation, and preferably the most efficient culture condition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968953     DOI: 10.1007/s13577-012-0045-4

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  31 in total

Review 1.  Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential.

Authors:  Richard O C Oreffo; Cyrus Cooper; Christopher Mason; Mark Clements
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

2.  Growth factors reduce the suppression of proliferation and osteogenic differentiation by titanium particles on MSCs.

Authors:  Woong-Kyo Jeong; Sang-Won Park; Gun-Il Im
Journal:  J Biomed Mater Res A       Date:  2008-09-15       Impact factor: 4.396

3.  Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.

Authors:  Ali Fakhry; Chootima Ratisoontorn; Charulatha Vedhachalam; Imad Salhab; Eiki Koyama; Phoeby Leboy; Maurizio Pacifici; Richard E Kirschner; Hyun-Duck Nah
Journal:  Bone       Date:  2005-02       Impact factor: 4.398

4.  Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation.

Authors:  M J Coelho; M H Fernandes
Journal:  Biomaterials       Date:  2000-06       Impact factor: 12.479

5.  Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.

Authors:  Panagiota A Sotiropoulou; Sonia A Perez; Maria Salagianni; Constantin N Baxevanis; Michael Papamichail
Journal:  Stem Cells       Date:  2005-08-18       Impact factor: 6.277

6.  Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes.

Authors:  Louis M Scavo; Michael Karas; Malissa Murray; Derek Leroith
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

7.  FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4).

Authors:  Nan E Hatch; Francisco Nociti; Erica Swanson; Mark Bothwell; Martha Somerman
Journal:  Connect Tissue Res       Date:  2005       Impact factor: 3.417

8.  Strategy for generating tissue-engineered human bone construct.

Authors:  K K Tan; B S Aminuddin; G H Tan; M Sabarul Afian; M H Angela Ng; O Fauziah; B H I Ruszymah
Journal:  Med J Malaysia       Date:  2004-05

9.  Repair of large osteochondral defects with allogeneic cartilaginous aggregates formed from bone marrow-derived cells using RWV bioreactor.

Authors:  Tomokazu Yoshioka; Hajime Mishima; Yoshimi Ohyabu; Shinsuke Sakai; Hiroshi Akaogi; Tomoo Ishii; Hiroko Kojima; Junzo Tanaka; Naoyuki Ochiai; Toshimasa Uemura
Journal:  J Orthop Res       Date:  2007-10       Impact factor: 3.494

10.  Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation.

Authors:  Birgit Kulterer; Gerald Friedl; Anita Jandrositz; Fatima Sanchez-Cabo; Andreas Prokesch; Christine Paar; Marcel Scheideler; Reinhard Windhager; Karl-Heinz Preisegger; Zlatko Trajanoski
Journal:  BMC Genomics       Date:  2007-03-12       Impact factor: 3.969

View more
  2 in total

1.  Human adipose tissue derived stem cells as a source of smooth muscle cells in the regeneration of muscular layer of urinary bladder wall.

Authors:  Salah Abood Salem; Angela Ng Min Hwie; Aminuddin Saim; Christopher Ho Chee Kong; Ismail Sagap; Rajesh Singh; Mohd Reusmaazran Yusof; Zulkifili Md Zainuddin; Ruszymah Hj Idrus
Journal:  Malays J Med Sci       Date:  2013-07

2.  Repair of segmental load-bearing bone defect by autologous mesenchymal stem cells and plasma-derived fibrin impregnated ceramic block results in early recovery of limb function.

Authors:  Min Hwei Ng; Suryasmi Duski; Kok Keong Tan; Mohd Reusmaazran Yusof; Kiat Cheong Low; Isa Mohamed Rose; Zahiah Mohamed; Aminuddin Bin Saim; Ruszymah Bt Hj Idrus
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.